Soylu-Kucharz R, Khoshnan A, Petersen A
iScience. 2022; 25(2):103771.
PMID: 35146388
PMC: 8819015.
DOI: 10.1016/j.isci.2022.103771.
Bianchi V, Rizzi L, Bresciani E, Omeljaniuk R, Torsello A
J Endocr Soc. 2020; 4(11):bvaa120.
PMID: 33094209
PMC: 7568521.
DOI: 10.1210/jendso/bvaa120.
Nobrega C, Conceicao A, Costa R, Koppenol R, Sequeira R, Nunes R
BMC Res Notes. 2020; 13(1):210.
PMID: 32276655
PMC: 7149904.
DOI: 10.1186/s13104-020-05053-x.
Cheong R, Gabery S, Petersen A
J Huntingtons Dis. 2019; 8(4):375-391.
PMID: 31594240
PMC: 6839491.
DOI: 10.3233/JHD-190372.
Bras I, Konig A, Outeiro T
J Huntingtons Dis. 2019; 8(3):245-256.
PMID: 31322580
PMC: 6839463.
DOI: 10.3233/JHD-190366.
Morphological features in juvenile Huntington disease associated with cerebellar atrophy - magnetic resonance imaging morphometric analysis.
Hedjoudje A, Nicolas G, Goldenberg A, Vanhulle C, Dumant-Forrest C, Deverriere G
Pediatr Radiol. 2018; 48(10):1463-1471.
PMID: 29926145
DOI: 10.1007/s00247-018-4167-z.
Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.
Parievsky A, Moore C, Kamdjou T, Cepeda C, Meshul C, Levine M
Neurobiol Dis. 2017; 108:29-44.
PMID: 28757327
PMC: 5675804.
DOI: 10.1016/j.nbd.2017.07.020.
Theory of mind and empathy in preclinical and clinical Huntington's disease.
Adjeroud N, Besnard J, El Massioui N, Verny C, Prudean A, Scherer C
Soc Cogn Affect Neurosci. 2015; 11(1):89-99.
PMID: 26211015
PMC: 4692318.
DOI: 10.1093/scan/nsv093.
Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease.
Galvan L, Andre V, Wang E, Cepeda C, Levine M
J Huntingtons Dis. 2014; 1(1):17-25.
PMID: 25063187
PMC: 4116084.
DOI: 10.3233/JHD-2012-120009.
A two years longitudinal study of a transgenic Huntington disease monkey.
Chan A, Xu Y, Jiang J, Rahim T, Zhao D, Kocerha J
BMC Neurosci. 2014; 15:36.
PMID: 24581271
PMC: 4015530.
DOI: 10.1186/1471-2202-15-36.
Functions of huntingtin in germ layer specification and organogenesis.
Nguyen G, Molero A, Gokhan S, Mehler M
PLoS One. 2013; 8(8):e72698.
PMID: 23967334
PMC: 3742581.
DOI: 10.1371/journal.pone.0072698.
Selective roles of normal and mutant huntingtin in neural induction and early neurogenesis.
Nguyen G, Gokhan S, Molero A, Mehler M
PLoS One. 2013; 8(5):e64368.
PMID: 23691206
PMC: 3653864.
DOI: 10.1371/journal.pone.0064368.
Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease.
Kandasamy M, Reilmann R, Winkler J, Bogdahn U, Aigner L
Neurol Res Int. 2011; 2011:124256.
PMID: 21766020
PMC: 3134994.
DOI: 10.1155/2011/124256.
Striatal and white matter predictors of estimated diagnosis for Huntington disease.
Paulsen J, Nopoulos P, Aylward E, Ross C, Johnson H, Magnotta V
Brain Res Bull. 2010; 82(3-4):201-7.
PMID: 20385209
PMC: 2892238.
DOI: 10.1016/j.brainresbull.2010.04.003.
Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Gray M, Shirasaki D, Cepeda C, Andre V, Wilburn B, Lu X
J Neurosci. 2008; 28(24):6182-95.
PMID: 18550760
PMC: 2630800.
DOI: 10.1523/JNEUROSCI.0857-08.2008.
